会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Animal with gene hypoexpression
    • 动物与基因低表达
    • US07462757B2
    • 2008-12-09
    • US10478466
    • 2002-05-21
    • Tomoko SatomiRyuichi TozawaMitsugu NakataYoshitaka YasuharaYoshio Taniyama
    • Tomoko SatomiRyuichi TozawaMitsugu NakataYoshitaka YasuharaYoshio Taniyama
    • A01K67/00A01K67/027G01N33/00
    • C12N15/907A01K2217/075C12N2517/02
    • The present invention relates to non-human animal embryonic stem cells in which a lecithin:cholesterol acyltransferase-like lysophospholipase endogenous gene is inactivated; non-human animals deficient in expression of LLPL gene; methods of screening for prophylactics and/or therapeutic drug using the cells or the animals; and prophylactics and/or therapeutic drug obtainable by the screening.The non-human animal ES cells of the invention in which their LLPL gene is inactivated are very useful in creating non-human animals deficient in expression of LLPL gene. The LLPL expression deficient non-human animals of the invention can be disease models for such diseases caused by insufficiency of the biological activities of LLPL since the animals lack various biological activities inducible by LLPL. Therefore, the animals of the invention are useful in screening for prophylactics and/or therapeutic drug for various diseases resulting from LLPL deficiency, as well as in elucidating the causes of LLPL-related diseases and examining therapeutic methods for such diseases. The screening methods of the invention are capable of efficiently screening for prophylactics and/or therapeutic drug for various diseases resulting from LLPL deficiency.
    • 本发明涉及非人动物胚胎干细胞,其中卵磷脂:胆固醇酰基转移酶样溶血磷脂酶内源基因失活; 非人类动物缺乏LLPL基因的表达; 使用细胞或动物筛选预防和/或治疗药物的方法; 以及通过筛选可获得的预防和/或治疗药物。 其LLPL基因失活的本发明的非人动物ES细胞非常有用于产生缺乏LLPL基因表达的非人动物。 本发明的LLPL表达缺陷型非人动物可以是LLPL生物活性不足引起的疾病的疾病模型,因为动物缺乏由LLPL诱导的各种生物活性。 因此,本发明的动物可用于筛选由LLPL缺乏引起的各种疾病的预防和/或治疗药物,以及阐明LLPL相关疾病的原因并检查这些疾病的治疗方法。 本发明的筛选方法能够有效筛选由LLPL缺乏引起的各种疾病的预防和/或治疗药物。